Wholesale professional products for aesthetic clinics and practitioners

BLOG

Nabota vs Botox: What’s the Real Difference?

Short answer: less than you think. Nabota and Botox are both botulinum toxin type A built on the same 900 kDa complex, both vacuum-dried (both vials look almost empty), and head-to-head clinical studies using identical unit dosing found comparable onset, duration and safety. The real differences are the manufacturer (Daewoong in Korea vs AbbVie/Allergan in the US), the regulatory history, and a wholesale price that is typically 30–50% lower for Nabota.

Nabota vs Botox at a Glance

Botox Nabota
Manufacturer Allergan / AbbVie (USA) Daewoong Pharmaceutical (South Korea)
Molecule OnabotulinumtoxinA Botulinum toxin type A, 900 kDa complex (high-purity, Daewoong-reported ~98%)
In-vial appearance Vacuum-dried — looks almost empty Vacuum-dried — looks almost empty (same process)
Key approvals US FDA cosmetic approval 2002; decades of therapeutic indications Korean MFDS approval 2013–2014; exported worldwide; the same Daewoong molecule is sold in the US by Evolus as Jeuveau, FDA-approved 2019
Onset ~2–3 days ~2–3 days (studies report as early as 2 days)
Duration ~3–4 months ~3–4 months in head-to-head trials
Clinical dosing Reference standard Studied at identical unit doses (e.g. 20U glabellar), non-inferior results
Wholesale price tier Premium Typically 30–50% lower

Same Molecule Class, Same Manufacturing Look

Both products are type A botulinum toxin bound in the classic 900 kDa protein complex, and both are dried under vacuum — which is why a brand-new vial of either one can look alarmingly empty. If you have ever wondered about that, our guide on why a new Botox vial looks almost empty explains the vacuum-drying process in detail, with real photos of Nabota next to freeze-dried brands.

The active contents are also dosed the same way in practice: reconstitution volumes, injection patterns and treatment intervals in the clinical literature are essentially interchangeable workflows. For dilution math, see our saline mixing guide for 100U vials and the units vs mL reference.

Regulatory Status: Botox, Nabota and Jeuveau Explained

This is the part that confuses most buyers, so here is the clean version:

Botox is the original: FDA-approved for glabellar lines since 2002, with a therapeutic track record going back to 1989. It is the most studied botulinum toxin in the world, full stop.

Nabota is Daewoong’s brand for the Korean and export markets, approved by Korea’s MFDS in 2013–2014 and now registered in dozens of countries. Jeuveau (prabotulinumtoxinA-xvfs) is the same Daewoong-made molecule branded by Evolus for the United States, FDA-approved in February 2019 — which is why you will hear practitioners describe Nabota as “the Korean toxin with an FDA-approved sibling.” Korea’s second FDA-entrant, Hugel’s Letybo (letibotulinumtoxinA), followed in February 2024. For the bigger picture, read What is Korean Botox?.

Buying note: in markets where Nabota itself is the registered brand, you buy Nabota. In the US, the equivalent product reaches clinics as Jeuveau. Same Daewoong manufacturing, different boxes.

What the Clinical Studies Show

Nabota’s pivotal glabellar-line trials, and Jeuveau’s FDA program behind it, were built on the same dosing clinicians use for Botox — 20 units across five injection points. The results:

1. Efficacy: responder rates for frown-line improvement were comparable to the onabotulinumtoxinA benchmark, and in Jeuveau’s head-to-head comparison the product met non-inferiority criteria against Botox.

2. Onset and duration: visible effect typically within 2–3 days, duration in the same 3–4 month band, with some studies reporting a marginally faster onset for the Daewoong molecule.

3. Safety: adverse-event profiles were similar — transient headache, eyelid heaviness and injection-site reactions at low rates, no new safety signals.

One precise nuance: every manufacturer label states that units of different toxin products are not interchangeable. That is a regulatory statement about how units are defined per assay — not a finding that one product is weaker. The practical takeaway from the trials is that studied at equal labelled units, the two products performed equivalently.

Price: Why Nabota Costs 30–50% Less

The gap is structural, not a quality signal:

1. Manufacturing economics. Daewoong produces at Korean cost levels with modern facilities built decades after Allergan’s, on a platform designed for efficient export.

2. No legacy brand premium. Botox pricing carries forty years of brand equity, the largest medical-aesthetics marketing machine in the industry, and US market overheads. Nabota’s strategy is the opposite: win on value and let distributor margins stay attractive.

3. What it means per vial. For a clinic reconstituting several 100U vials a week, switching a share of volume to Nabota typically saves hundreds of dollars per month at identical labelled dosing — which is exactly why high-volume practices adopted it first.

Which One Should Your Clinic Choose?

Honest answer: many clinics stock both, and assign by patient profile.

Choose Botox when the patient asks for it by name, when your positioning is premium-brand-led, or when a documented decades-long track record matters for consent conversations.

Choose Nabota when you treat at volume, when patients are price-aware, or when you want premium-format quality (same vacuum-dried process, high purity) at Korean pricing. Most patients cannot tell the difference in the mirror — and in the studies, investigators largely could not either.

Also on the Korean shelf: Botulax (Hugel’s freeze-dried workhorse), ReNTOX (a refined Botulax successor with very low protein load), and Innotox (the world’s only ready-to-use liquid toxin — no reconstitution at all).

MJS Beauty note: this comparison summarises published trials and public regulatory records for qualified practitioners and informed buyers. It is not medical advice; product choice, dosing and injection remain the treating practitioner’s professional decision. Always buy through verified channels and confirm batch authenticity on arrival.

Common Questions, Answered Fast

Is Nabota the same as Botox?

Not the same brand, but the same class: both are botulinum toxin type A on the 900 kDa complex, both vacuum-dried, studied at identical unit dosing with comparable results. The differences are the manufacturer, the regulatory history and the price — not the mechanism.

Is Nabota FDA approved?

Nabota as a brand is approved by Korea’s MFDS and regulators in many other countries. In the United States, the same Daewoong molecule is marketed by Evolus as Jeuveau (prabotulinumtoxinA-xvfs), FDA-approved in February 2019 for glabellar lines. So the molecule behind Nabota does have an FDA-approved identity — under a different label.

Are Nabota units the same as Botox units?

Labels of all toxin products state that units are product-specific and not formally interchangeable, because each manufacturer defines its unit by its own assay. In practice, the pivotal trials dosed Nabota and Jeuveau at exactly the same unit numbers used for Botox (for example 20U for glabellar lines) and achieved non-inferior results — so clinical dosing mirrors Botox 1:1 in the published evidence.

Does Nabota last as long as Botox?

In head-to-head data, yes — both sit in the 3–4 month duration band for glabellar treatment, with onset in about 2–3 days. Individual duration always varies with metabolism, dose, muscle strength and injection technique more than with brand.

Why is Nabota so much cheaper?

Manufacturing economics and brand strategy, not weaker quality: Korean production costs, no legacy brand premium, and a deliberate value-positioning strategy. The purity and clinical data are on the record; the 30–50% lower wholesale price is simply what makes it disruptive.

Is Korean botulinum toxin safe to use?

Licensed Korean toxins such as Nabota, Botulax, ReNTOX and Innotox are manufactured by major pharmaceutical companies (Daewoong, Hugel, Medytox) under MFDS oversight, with two Korean molecules now also holding FDA approvals (Jeuveau 2019, Letybo 2024). The genuine safety risk in this market is counterfeits, not Korea — buy from verified suppliers and check batch codes. More in What is Korean Botox?.

What about Botulax, ReNTOX or Innotox vs Botox?

Same class, different formats. Botulax and ReNTOX are freeze-dried powders (visible white ring in the vial) with the same type A mechanism at similar value pricing; Innotox is a ready-to-use liquid that removes reconstitution entirely. All three are Korean-made alternatives clinics use to balance cost and workflow — see the full botulinum toxin category for formats and vial sizes.

Compare Them on Your Own Shelf

The fastest way to judge is hands-on: order a vial of Nabota 100U, run it side by side with your current brand, and compare onset, duration and patient feedback over one treatment cycle. Questions about formats, pricing tiers or mixed orders? Contact the MJS Beauty team.

View Botulinum Toxin CategoryContact Us

NEOGENESIS PDO Tornado Screw Multi Thread 20ea/Pack — Tornado Twisted Filament PDO Thread

$53.00

Neogenesis PDO Tornado Screw Multi Thread 20ea/Pack — two PDO filaments wound around a Basic Needle (two screw / tornado) for facial oval and moderate nasolabial folds. Eight sizes, all Basic Needle. CE / KFDA. For licensed practitioners.

NEOGENESIS PDO Triple Multi Thread 20ea/Pack — Twisted Triple Filament PDO Thread

$53.00

Neogenesis PDO Triple Multi Thread 20ea/Pack — three twisted PDO filaments (three stranded) for brow / crow’s-feet region, puppet wrinkles, abdomen and inner thighs. Eight sizes, all Basic Needle. CE / KFDA. For licensed practitioners.

NEOGENESIS PDO Twin Multi Thread 20ea/Pack — Twisted Double Filament PDO Thread

$48.00

Neogenesis PDO Twin Multi Thread 20ea/Pack — two twisted PDO filaments (two stranded) for crow’s feet, nasolabial folds, lower-third support and marionette lines. Nine sizes, all Basic Needle. CE / KFDA. For licensed practitioners.

NEOGENESIS PDO Cavern Thread — Body Lifting Cog Thread 10ea/Pack (L-Type & SS-Type Cannula)

Price range: $76.00 through $85.00

Neogenesis PDO Cavern Thread 10ea/Pack — coil-spring PDO (hollow cavern) on L-type or SS-type cannula. Volumizing scaffold for zygomatic arch, nasolabial folds and brow; 19G SS for longer paths. CE / KFDA. For licensed practitioners.

NEOGENESIS PDO Thread Filler — L-Type Cannula Thread 10ea/Pack

$86.00

Neogenesis PDO Thread Filler 10ea/Pack — 20 linear PDO strands on a 23G L-type cannula (TF2338-C 38/50mm or TF2360-C 60/90mm). Soft volumetric filling for inner brow, zygomatic arch and nasolabial folds. CE / KFDA. For licensed practitioners.

NEOGENESIS Mesh Thread — Woven Mesh Volumizing Thread 10ea/Pack

$86.00

Neogenesis Mesh Thread 10ea/Pack — woven PDO lattice (USP 6-0) on a 19G L-type cannula (MS1938-C 38/50mm or MS1950-C 50/60mm). Soft volumizing for nasolabial folds and the lower third of the face. CE / KFDA. For licensed practitioners.

NEOGENESIS PDO Double Needle Thread — Multi-Directional Combi PDO Thread (1ea/Pack)

Price range: $49.00 through $55.00

Neogenesis PDO Double Needle Thread 1ea/Pack — multi-directional Combi PDO (USP 2-0) with a blunt needle at each end (D19110S 290mm / D19110L 440mm). Loop fixation for forehead, brow, jaw line, neck, chest and buttocks. CE / KFDA. For licensed practitioners.

SK+XA 20 mg (10 Vials)

$86.00
Composition Selank + Semax: composition and pack details 01 Active ingredients Selank 10 mg + Semax 10 mg per vial.

SX10 10 mg (10 Vials)

$68.00
Composition Semax: composition and pack details 01 Active ingredient Semax. 02 Peptide identity Heptapeptide · sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). 03 Vial

CU100 100 mg (10 Vials)

$38.00
Composition GHK-CU: composition and pack details 01 Active ingredient GHK-Cu. 02 Peptide identity Copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK).
Chat with MJS on WhatsApp
Shopping cart
Sign in

No account yet?

Shop
Wishlist
0 items Cart
My account